Efficacy News and Research

RSS
Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy

Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy

Additional Zenvia Phase III results in multiple sclerosis announced by AVANIR

Additional Zenvia Phase III results in multiple sclerosis announced by AVANIR

FDA Advisory Committee approves use of Selzentry tablets in combination with HIV therapy

FDA Advisory Committee approves use of Selzentry tablets in combination with HIV therapy

Number of doses, delivery system and setting impact radiation price tag

Number of doses, delivery system and setting impact radiation price tag

New soy germ-based ingredient improves menopausal symptoms

New soy germ-based ingredient improves menopausal symptoms

Berkshire Partners makes $125 million growth equity investment to support United BioSource

Berkshire Partners makes $125 million growth equity investment to support United BioSource

Research study on HPV vaccination efficacy for boys and girls

Research study on HPV vaccination efficacy for boys and girls

Refurbished pacemakers: No complications for patients

Refurbished pacemakers: No complications for patients

CardioPharma to submit an NDA for CardiaPill

CardioPharma to submit an NDA for CardiaPill

Lpath reports positive Phase 1 clinical trial results of iSONEP in wet-AMD patients

Lpath reports positive Phase 1 clinical trial results of iSONEP in wet-AMD patients

Valensa initiates licensing patent for the use of the astaxanthin as a dietary supplement

Valensa initiates licensing patent for the use of the astaxanthin as a dietary supplement

CombinatoRx' Prednisolone/Dipyridamole Combination abstract to be presented at the ACR 2009

CombinatoRx' Prednisolone/Dipyridamole Combination abstract to be presented at the ACR 2009

Clinical and health status outcomes information repository of heart attack patients completed

Clinical and health status outcomes information repository of heart attack patients completed

Mimetogen Pharmaceuticals completes its equity financing

Mimetogen Pharmaceuticals completes its equity financing

Kylin Therapeutics receives notice of allowance for its first U.S. patent application

Kylin Therapeutics receives notice of allowance for its first U.S. patent application

Labopharm's trazodone API supplier Angelini resolves manufacturing facility deficiencies

Labopharm's trazodone API supplier Angelini resolves manufacturing facility deficiencies

Triple therapy may benefit patients with chronic obstructive pulmonary disease

Triple therapy may benefit patients with chronic obstructive pulmonary disease

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

Entest BioMedical applies for Phase II grant from National Cancer Institute

Entest BioMedical applies for Phase II grant from National Cancer Institute

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.